摘要
非酒精性脂肪性肝炎(NASH)作为患病率较高的一种肝病,严重危害人类健康。近年来,法尼醇X受体相关药物在调节胆汁酸、糖脂代谢以及抑制炎症方面发挥了重要作用。总结了不同种类的法尼醇X受体激动剂在NASH治疗中的应用,为NASH的防治提供一定的依据。
Nonalcoholic steatohepatitis(NASH)is a liver disease with a relatively high prevalence worldwide and greatly threatens human health.In recent years,farnesoid X receptor-related drugs have played an important role in regulating the metabolism of bile acid,glu-cose,and lipids and inhibiting inflammation.This article summarizes the application of farnesoid X receptor agonists in the treatment of NASH,so as to provide a basis for the prevention and treatment of NASH.
作者
沈镇扬
蔡晓波
陆伦根
SHEN Zhenyang;CAI Xiaobo;LU Lungen(Department of Gastroenterology,Shanghai General Hospital,Shanghai Jiao Tong University,Shanghai 200080,China)
出处
《临床肝胆病杂志》
CAS
北大核心
2022年第6期1402-1405,共4页
Journal of Clinical Hepatology
基金
国家自然科学基金(81970528)。